Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience

Debates on the role and timing of allogeneic hemtopoietic stem cell transplantation (HSCT) in acute myelogenous leukemia (AML) have persisted for decades. Time to transplant introduces an immortal time and current treatment algorithm mainly relies on the European LeukemiaNet disease risk classificat...

Descripción completa

Detalles Bibliográficos
Autores principales: Socie, Gerard, Galimard, Jacques-Emmanuel, Raffoux, Emmanuel, Itzykson, Raphael, Debureaux, Pierre Edouard, Michonneau, David, Lengliné, Etienne, Robin, Marie, de Fontbrune, Flore Sicre, Sébert, Marie, Xhaard, Aliénor, Kim, Rathana, Couprie, Anne, Dhedin, Nathalie, Dragani, Matteo, Lemaire, Pierre, Larcher, Lise, Clappier, Emmanuelle, Boissel, Nicolas, Soulier, Jean, Dombret, Hervé, Fenaux, Pierre, de Latour, Régis Peffault, Adès, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Bone Marrow Transplant
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483356/
https://www.ncbi.nlm.nih.gov/pubmed/36951151
http://dx.doi.org/10.3324/haematol.2023.282729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483356/
https://www.ncbi.nlm.nih.gov/pubmed/36951151
http://dx.doi.org/10.3324/haematol.2023.282729

Ejemplares similares